Novelix Pharmaceuticals Submits FY26 Annual Report & AGM Notice

Novelix Pharmaceuticals Ltd has submitted its annual report for the financial year ended March 31, 2026, in compliance with SEBI Listing Regulations. The report includes the notice for the 32nd Annual General Meeting (AGM) scheduled for September 30, 2026, to be held via Video Conferencing. The company, formerly Trimurti Limited, is undergoing a strategic transition into the pharmaceutical sector, focusing on innovation, quality, and sustainable growth. It aims to leverage its legacy to build a strong presence in the pharmaceutical industry, emphasizing quality-driven operations and solutions for evolving healthcare needs. The company is also sending web-links for accessing the AGM notice and annual report to members who have not registered their email IDs.